Additionally, in our study, plasmatic levels of hsTNT and proBNP were correlated with COVID-19 severity and emphasized the importance of cardiovascular injury markers as risk estimation tools for phenotypes of COVID-19 with low-grade inflammation in non-ICU settings. Here, NPPB is linked to COVID-19.